Search
for
Sort by
Research 61–90 of 71
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Is polycystic ovarian syndrome and insulin resistance associated with abnormal uterine bleeding in adolescents?
- The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review
- Follow-up care after metabolic surgery – a prospective study in the North-Eastern region of Romania
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Body image and mental health in women with polycystic ovary syndrome–a cross-sectional study
- Debatable Topics in PCOS Patients
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Health-related quality of life and mental state in women with polycystic ovary syndrome and migration or minority background – A cross-sectional study
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions
- HAIR-AN Syndrome: A Systematic Review of Clinical, Metabolic, and Hormonal Features in Women of Reproductive Age
- Hair loss during treatment of obesity: current state of the problem and potential solutions
- Nutritive diet becomes unhealthy if taken in a wrong ratio: Scientific validation of Ayurvedic concept of “incompatible diet” (<i>Virrudh Aahar</i>)
- Polycystic ovary syndrome and infertility: an update
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- Poster Abstracts
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin